Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine

Journal of Clinical Psychopharmacology

Volumn 22, Issue 2, 2002, Pages 174-182

  Potkin, Steven G ^a   Thyrum, Per T ^a   Alva, Gustavo ^a   Carreon, Danilo ^a   Yeh, Chiao ^a   Kalali, Amir ^a   Arvanitis, Lisa A ^a   Fabre Jr , Louis Fernand ^a   Holland, Peter ^a   Carman, John S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; NEUROLEPTIC AGENT; NORFLUOXETINE; QUETIAPINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MULTICENTER STUDY; PHARMACOKINETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOIDISM; SCHIZOPHRENIA; SIDE EFFECT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HUMANS; IMIPRAMINE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 0036215039     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200204000-00011     Document Type: Article

References (28)

1. ICI 204,636 (SEROQUEL). A dibenzothiazepine atypical antipsychotic. Review of preclinical pharmacology and highlights of phase II clinical trials
2. In vitro prediction of potential metabolic drug interactions for Seroquel
3. Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P450 3A4 in human liver
4. The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine
5. The effect of selective serotonin reuptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes
6. Psychiatry, psychopharmacology and P-450s
7. Antidepressant drug interactions and the cytochrome P450 system: A critical appraisal
8. The effects of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam
9. Fluoxetine impairs clearance of alprazolam but not of clonazepam
10. Serum concentrations of clozapine and its major metabolites: Effects of co-treatment with fluoxetine and valproate
11. Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction
12. The UKU side effect rating scale
13. A rating scale for extrapyramidal side effects
14. The brief psychiatric rating scale
15. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
16. The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations
17. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline
18. Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: In vitro and in vivo studies
19. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism
20. Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system
21. ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia
22. Quetiapine in patients with schizophrenia: A high- and low-dose double-blind comparison with placebo
23. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
24. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia